LIPELLA PHARMACEUTICALS INC. (LIPO)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 86,727 | 129,390 | 80,380 | 136,431 |
| Research and development | 791,581 | 993,475 | 1,046,693 | 661,558 |
| General and administrative | 651,721 | 463,736 | 493,102 | 427,062 |
| Total costs and expenses | 1,443,302 | 1,457,211 | 1,539,795 | 1,088,620 |
| Loss from operations | -1,356,575 | -1,327,821 | -1,459,415 | -952,189 |
| Interest income, net | 29,089 | 21,298 | 14,778 | 14,043 |
| Total other income/(expense) | 29,089 | 21,298 | 14,778 | 14,043 |
| Loss before income taxes | -1,327,486 | -1,306,523 | -1,444,637 | -938,146 |
| Provision for income taxes | - | - | - | - |
| Net loss | -1,327,486 | -1,306,523 | -1,444,637 | -938,146 |
| Basic | -0.31 | -0.64 | -1.29 | -0.12 |
| Basic | 4,305,243 | 2,056,804 | 1,119,129 | 7,605,636 |
| Dilutive | -0.31 | -0.64 | -1.29 | -0.12 |
| Dilutive | 4,305,243 | 2,056,804 | 1,119,129 | 7,605,636 |